Compounds > bromfenac
Page last updated: 2024-08-24

bromfenac and Disease Models, Animal

bromfenac has been researched along with Disease Models, Animal in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Chen, N; Li, W; Liu, J; Liu, X; Nie, A; Song, L1
García-Arzate, D; García-Sánchez, GA; García-Santisteban, R; Gonzalez-Salinas, R; Hernández-Piñamora, E; Linares-Alba, MA; Morales-Cantón, V; Quiroz-Mercado, H; Rodríguez-Reyes, AA; Sánchez-Santos, I; Tirado-González, V1
Grzybowski, A; He, J; Hua, S; Li, W; Qi, Y; Qiao, Y; Santos, HA; Wang, W; Yao, K; Ye, Y; Zhang, H; Zhong, D; Zhou, M1
Agudo-Barriuso, M; Nadal-Nicolás, FM; Rovere, G; Sobrado-Calvo, P; Vidal-Sanz, M; Villegas-Pérez, MP1
Crosson, C; Husain, S; Katoli, P; Kelly, C; Li, L; Scott, D; Sharif, NA; Toris, C; Xu, S1
Agudo-Barriuso, M; García-Bernal, D; Nadal-Nicolás, FM; Rovere, G; Sobrado-Calvo, P; Vidal-Sanz, M; Villegas-Pérez, MP1
Higaki, S; Itahashi, M; Shimomura, Y; Watanabe, K1
Hashimoto, T; Hoshina, F; Igarashi, A; Kohno, S; Notsu, Y; Toyoda, Y; Yamada, M1

Trials

1 trial(s) available for bromfenac and Disease Models, Animal

ArticleYear
The Effect of Bromfenac Sodium Nanopolymer Used in Anterior Segment of the Eye on Corneal Neovascularization.
    Cellular and molecular biology (Noisy-le-Grand, France), 2022, Mar-31, Volume: 68, Issue:3

    Topics: Animals; Benzophenones; Bromobenzenes; Burns, Chemical; Corneal Neovascularization; Cyclooxygenase 2; Disease Models, Animal; Eye Burns; Rabbits; Vascular Endothelial Growth Factor A

2022

Other Studies

7 other study(ies) available for bromfenac and Disease Models, Animal

ArticleYear
Intravitreal bromfenac liposomal suspension (100 μg / 0.1 ml). A safety study in rabbit eyes.
    Experimental eye research, 2020, Volume: 194

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intravitreal Injections; Liposomes; Macula Lutea; Macular Edema; Rabbits; Suspensions; Treatment Outcome

2020
Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis.
    Theranostics, 2020, Volume: 10, Issue:19

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Benzophenones; Bromobenzenes; Cataract Extraction; Copper; Disease Models, Animal; Drug Synergism; Drug Therapy; Endophthalmitis; Gold; Humans; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Photothermal Therapy; Rabbits; Silver; Treatment Outcome

2020
Topical bromfenac transiently delays axotomy-induced retinal ganglion cell loss.
    Experimental eye research, 2019, Volume: 182

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Axotomy; Benzophenones; Bromobenzenes; Cell Count; Cell Survival; Disease Models, Animal; Female; Optic Nerve; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells

2019
FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys.
    Drug development research, 2014, Volume: 75, Issue:4

    Topics: Animals; Antihypertensive Agents; Benzophenones; Bromobenzenes; Cells, Cultured; CHO Cells; Cricetulus; Disease Models, Animal; Eye; Gene Expression Regulation; Humans; Macaca fascicularis; Ocular Hypertension; Quinolines; Receptor, Bradykinin B2; Swine

2014
Topical Treatment With Bromfenac Reduces Retinal Gliosis and Inflammation After Optic Nerve Crush.
    Investigative ophthalmology & visual science, 2016, Nov-01, Volume: 57, Issue:14

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Blotting, Western; Bromobenzenes; Cell Count; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Gliosis; Ophthalmic Solutions; Optic Disk; Optic Nerve Injuries; Optic Neuritis; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Tomography, Optical Coherence; Transcription Factor Brn-3A

2016
Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
    Current eye research, 2009, Volume: 34, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Benzopyrans; Bromobenzenes; Cornea; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; DNA, Viral; Etodolac; Female; Gene Dosage; Herpesvirus 1, Human; Keratitis, Herpetic; Mice; Mice, Inbred BALB C; Propionates; Reverse Transcriptase Polymerase Chain Reaction; Trigeminal Ganglion; Viral Load; Virus Activation; Virus Latency

2009
Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:6

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Benzophenones; Benzopyrans; Bromobenzenes; Conjunctivitis, Allergic; Diclofenac; Dinoprostone; Disease Models, Animal; Evans Blue; Exudates and Transudates; Eye; Guinea Pigs; Histamine; Histamine Release; Immunization; Injections, Intraperitoneal; Injections, Subcutaneous; Ketotifen; Male; Ovalbumin; Propionates; Prostaglandin D2; Pruritus; Therapeutic Irrigation

2003